All | PD | HD | ||||||
---|---|---|---|---|---|---|---|---|
Planned-start | Emergent-start | p value | Planned-start | Emergent-start | p value | |||
AVF/AVG | CVC | |||||||
N | 507 | 43 | 68 | – | 116 | 243 | 37 | – |
Men, n (%) | 288 (56.8) | 21 (48.8) | 40 (58.8) | 0.303a | 65 (56.0) | 140 (57.6) | 22 (59.5) | 0.925a |
Age, years, n (%) | 61.8 ± 15.5 | 52.1 ± 10.2 | 49.3 ± 13.3 | 0.327b | 67.3 ± 13.2 | 63.8 ± 14.6 | 61.8 ± 15.5 | 0.075d |
 ≧65 | 233 (44.0) | 4 (9.3) | 8 (11.8) | 0.763c | 69 (59.5) | 119 (49.0) | 23 (62.2) | 0.092a |
Predialysis education program | 281 (55.4) | 32 (74.4) | 30 (44.1) | 0.002a | 106 (91.4)*# | 100 (41.2)* | 13 (35.1)# | < 0.001a |
Primary renal diseases, n (%) | ||||||||
 Diabetes mellitus | 217 (42.8) | 10 (23.3) | 17 (25.0) | 0.835a | 56 (48.3) | 119 (49.0) | 15 (40.5) | 0.631a |
 Glomerulonephritis | 115 (22.7) | 16 (37.2) | 30 (44.1) | 0.472a | 18 (15.5) | 42 (17.3) | 9 (24.3) | 0.467a |
 Others | 175 (34.5) | 17 (39.5) | 21 (30.9) | 0.349a | 42 (36.2) | 82 (33.7) | 13 (35.1) | 0.898a |
Comorbidities, n (%) | ||||||||
 Diabetes mellitus | 247 (48.7) | 12 (27.9) | 19 (27.9) | 0.997a | 60 (51.7) | 139 (57.2) | 17 (45.9) | 0.338a |
 Hypertension | 426 (84.0) | 38 (88.4) | 56 (82.4) | 0.391a | 99 (85.3) | 207 (85.2) | 26 (70.3) | 0.062a |
 Hyperlipidemia | 117 (23.1) | 9 (20.9) | 23 (33.8) | 0.144a | 27 (23.3) | 48 (19.8) | 10 (27.0) | 0.515a |
 CAD | 65 (12.8) | 4 (9.3) | 9 (13.2) | 0.763c | 10 (8.6) | 34 (14.0) | 8 (21.6) | 0.102a |
 CHF | 80 (15.8) | 3 (7.0) | 11 (16.2) | 0.241c | 10 (8.6)* | 50 (20.6)* | 6 (16.2) | 0.018a |
 VHD | 25 (4.9) | 1 (2.3) | 2 (2.9) | 1.000c | 2 (1.7) | 16 (6.6) | 4 (10.8) | 0.058a |
 CVA | 44 (8.7) | 2 (4.7) | 1 (1.5) | 0.558c | 12 (10.3) | 21 (8.6) | 8 (21.6) | 0.054a |
 PAOD | 27 (5.3) | 1 (2.3) | 5 (7.4) | 0.402c | 5 (4.3) | 14 (5.8) | 2 (5.4) | 0.848a |
 Cancer | 44 (8.7) | 2 (4.7) | 1 (1.5) | 0.558c | 13 (11.2)# | 19 (7.8)$ | 9 (24.3)#$ | 0.008a |
Laboratory parameters | ||||||||
 Creatinine, mg/dl | 12.3 ± 5.1 | 12.6 ± 4.0 | 15.4 ± 6.1 | 0.008b | 11.2 ± 4.0 | 12.1 ± 5.1 | 12.3 ± 5.1 | 0.057d |
 eGFR, ml/min/1.73 m2 | 4.1 ± 1.8 | 3.9 ± 1.8 | 3.6 ± 2.0 | 0.111b | 4.1 ± 1.6# | 4.1 ± 1.8$ | 5.1 ± 2.2#$ | 0.020d |
 Albumin, g/dl | 3.6 ± 0.6 | 4.1 ± 0.5 | 3.7 ± 0.5 | 0.002b | 3.8 ± 0.5*# | 3.4 ± 0.6* | 3.6 ± 0.6# | < 0.001d |
 Hemoglobin, g/dl | 8.7 ± 1.6 | 9.1 ± 1.4 | 8.4 ± 1.9 | 0.130e | 9.3 ± 1.4* | 8.3 ± 1.5* | 8.7 ± 1.6 | < 0.001f |
 Potassium, mmol/l | 4.6 ± 0.9 | 4.5 ± 0.7 | 4.7 ± 0.9 | 0.365b | 4.5 ± 0.8 | 4.7 ± 1.0 | 4.6 ± 0.9 | 0.395d |
 Phosphorus, mg/dl | 6.7 ± 2.2 | 5.8 ± 1.5 | 7.7 ± 2.5 | < 0.001b | 5.9 ± 1.9* | 6.8 ± 2.2* | 6.7 ± 2.2 | 0.010d |